Biologická léčba VIII
LOTS
| Show detail | ||||
|---|---|---|---|---|
| N006/19/V00019382/001 | I. Bevacizumab | Antineoplastika | Awarded | |
| N006/19/V00019382/002 | II. Trastuzumab | Antineoplastika | Awarded | |
| N006/19/V00019382/003 | V. Vismodegib | Antineoplastika | Awarded | |
| N006/19/V00019382/003 | V. Vismodegib | Antineoplastika | Awarded | |
| N006/19/V00019382/004 | VI. Vemurafenib | Antineoplastika | Awarded | |
| N006/19/V00019382/004 | VI. Vemurafenib | Antineoplastika | Awarded | |
| N006/19/V00019382/005 | VII. Pirfenidon | Imunosupresiva | Awarded | |
| N006/19/V00019382/006 | III. Trastuzumab emtansin | Antineoplastika | Awarded | |
| N006/19/V00019382/007 | VIII. Okrelizumab | Imunosupresiva | Awarded | |
| N006/19/V00019382/008 | IV. Pertuzumab | Antineoplastika | Awarded |